These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 29999301)
21. Glycosaminoglycans bind factor Xa in a Ca2+-dependent fashion and modulate its catalytic activity. O'Brien LA; Stafford AR; Fredenburgh JC; Weitz JI Biochemistry; 2003 Nov; 42(44):13091-8. PubMed ID: 14596625 [TBL] [Abstract][Full Text] [Related]
22. Dual effect of Platelet Factor 4 on the activities of Factor Xa. Fiore MM; Mackie IJ Biochem Biophys Res Commun; 2009 Feb; 379(4):1072-5. PubMed ID: 19150337 [TBL] [Abstract][Full Text] [Related]
23. Interactions of Intact Unfractionated Heparin with Its Client Proteins Can Be Probed Directly Using Native Electrospray Ionization Mass Spectrometry. Zhao Y; Abzalimov RR; Kaltashov IA Anal Chem; 2016 Feb; 88(3):1711-8. PubMed ID: 26707758 [TBL] [Abstract][Full Text] [Related]
24. Identification of Protein Recognition Elements within Heparin Chains Using Enzymatic Foot-Printing in Solution and Online SEC/MS. Niu C; Zhao Y; Bobst CE; Savinov SN; Kaltashov IA Anal Chem; 2020 Jun; 92(11):7565-7573. PubMed ID: 32347711 [TBL] [Abstract][Full Text] [Related]
25. The Interaction of Factor Xa and IXa with Non-Activated Antithrombin in Michaelis Complex: Insights from Enhanced-Sampling Molecular Dynamics Simulations. Balogh G; Bereczky Z Biomolecules; 2023 May; 13(5):. PubMed ID: 37238665 [TBL] [Abstract][Full Text] [Related]
26. A non-hemorrhagic hybrid heparin/heparan sulfate with anticoagulant potential. Brito AS; Cavalcante RS; Palhares LC; Hughes AJ; Andrade GP; Yates EA; Nader HB; Lima MA; Chavante SF Carbohydr Polym; 2014 Jan; 99():372-8. PubMed ID: 24274520 [TBL] [Abstract][Full Text] [Related]
27. Comparative analysis of INLIGHT™-labeled enzymatically depolymerized heparin by reverse-phase chromatography and high-performance mass spectrometry. Mangrum JB; Mehta AY; Alabbas AB; Desai UR; Hawkridge AM Anal Bioanal Chem; 2017 Jan; 409(2):499-509. PubMed ID: 27888308 [TBL] [Abstract][Full Text] [Related]
28. Heparanase Activates Antithrombin through the Binding to Its Heparin Binding Site. Bohdan N; Espín S; Águila S; Teruel-Montoya R; Vicente V; Corral J; Martínez-Martínez I PLoS One; 2016; 11(6):e0157834. PubMed ID: 27322195 [TBL] [Abstract][Full Text] [Related]
29. Progressive chromogenic anti-factor Xa assay and its use in the classification of antithrombin deficiencies. Kovács B; Bereczky Z; Selmeczi A; Gindele R; Oláh Z; Kerényi A; Boda Z; Muszbek L Clin Chem Lab Med; 2014 Dec; 52(12):1797-806. PubMed ID: 24968404 [TBL] [Abstract][Full Text] [Related]
30. Osmotic stress regulates the anticoagulant efficiency of dermatan sulfate. McGee MP; Wagner W; Li L Matrix Biol; 2004 Oct; 23(6):363-70. PubMed ID: 15533757 [TBL] [Abstract][Full Text] [Related]
31. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis. Rosenberg RD Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697 [TBL] [Abstract][Full Text] [Related]
32. Protein adsorption on polyurethane catheters modified with a novel antithrombin-heparin covalent complex. Du YJ; Brash JL; McClung G; Berry LR; Klement P; Chan AK J Biomed Mater Res A; 2007 Jan; 80(1):216-25. PubMed ID: 17072855 [TBL] [Abstract][Full Text] [Related]
34. Optimization of a coagulation factor VIIa inhibitor found in factor Xa inhibitor library. Sagi K; Fujita K; Sugiki M; Takahashi M; Takehana S; Tashiro K; Kayahara T; Yamanashi M; Fukuda Y; Oono S; Okajima A; Iwata S; Shoji M; Sakurai K Bioorg Med Chem; 2005 Mar; 13(5):1487-96. PubMed ID: 15698764 [TBL] [Abstract][Full Text] [Related]
35. Mechanism of inhibition of the prothrombinase complex by a covalent antithrombin-heparin complex. Stevic I; Berry LR; Chan AK J Biochem; 2012 Aug; 152(2):139-48. PubMed ID: 22518847 [TBL] [Abstract][Full Text] [Related]
36. The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity. Dementiev A; Petitou M; Herbert JM; Gettins PG Nat Struct Mol Biol; 2004 Sep; 11(9):863-7. PubMed ID: 15311268 [TBL] [Abstract][Full Text] [Related]
37. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation. Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262 [TBL] [Abstract][Full Text] [Related]
38. Glycosaminoglycans as naturally occurring combinatorial libraries: developing a mass spectrometry-based strategy for characterization of anti-thrombin interaction with low molecular weight heparin and heparin oligomers. Abzalimov RR; Dubin PL; Kaltashov IA Anal Chem; 2007 Aug; 79(16):6055-63. PubMed ID: 17658885 [TBL] [Abstract][Full Text] [Related]
39. Dynamic properties of the native free antithrombin from molecular dynamics simulations: computational evidence for solvent- exposed Arg393 side chain. Tóth L; Fekete A; Balogh G; Bereczky Z; Komáromi I J Biomol Struct Dyn; 2015 Sep; 33(9):2023-36. PubMed ID: 25483839 [TBL] [Abstract][Full Text] [Related]
40. The superiority of anti-FXa assay over anti-FIIa assay in detecting heparin-binding site antithrombin deficiency. Kovács B; Bereczky Z; Oláh Z; Gindele R; Kerényi A; Selmeczi A; Boda Z; Muszbek L Am J Clin Pathol; 2013 Nov; 140(5):675-9. PubMed ID: 24124146 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]